Panjon

Indore, India Founded: 1964 • Age: 62 yrs Listed
Ayurvedic formulations are manufactured and supplied by Panjon.

About Panjon

Panjon is a publicly listed company based in Indore (India) founded in 1964 by Nagin Kothari and Nagin Bhai Kothari. Ayurvedic formulations are manufactured and supplied by Panjon. The company has 6 employees. Its chief executive, as recorded, is Jay Kothari. Its Indian entity Panjon Limited reported revenue of β‚Ή47.92 Cr. Panjon offers products and services including PANJON Balm and Swad Digestive Drops. Its focus areas include Alternative Medicine Products.

Company details

Panjon was established in 1964 in Indore, India, as a manufacturer and supplier within the ayurvedic sector. Formulations based on traditional Indian medicine are produced and distributed from this location. Operations center on healthcare products, with oversight by CEO and MD Jay Kothari, alongside founders Nagin Kothari and Nagin Bhai Kothari. The domain panjon.in supports business activities.

  • Headquarters Indore, India
  • Employees 6
  • Founders Nagin Kothari, Nagin Bhai Kothari
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website panjon.in
  • Social LinkedIn X Facebook
  • Legal Name Panjon Ltd
Key Metrics
  • Market Cap
    ₹29.73 Cr

    PANJON · BSE

  • Share Price
    ₹18.00

    +3.93% today

  • Revenue
    ₹12.26 Cr

    FY 2015-16 · -37.1% YoY

  • EBITDA
    −₹0.26 Cr

    Margin -2.1%

  • Net Profit
    ₹0.37 Cr

    FY 2015-16 · +110.8% YoY

  • P/E (TTM)
    53.8x

    P/B 1.8x

  • ROE
    1.8%

    ROCE 0.1%

  • Debt / Equity
    0.09

    Interest cover 0.0x

  • Employee Count
    6

Products & Services of Panjon

Panjon offers a comprehensive portfolio of products and services, including PANJON Balm and Swad Digestive Drops.

PANJON Balm
Health and Personal Care

A balm is provided for relief from ailments as part of the FMCG offerings.

Swad Digestive Drops
Confectionery

Digestive drops are offered to support health needs within the product range.

Board of directors of Panjon Limited (Panjon)

Panjon Limited is the primary company behind Panjon. The board of Panjon Limited currently have 5 directors; the longest-serving is Jay Kothari, appointed in 2015. 11 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Jay Kothari
DIN 00572543
Managing Director03 Sep 201511 yrs 2 moPanjon Limited
Pooja Vishal Bhandari
DIN 07867093
Director27 Sep 20179 yrs 1 moPanjon Limited
Anju Kothari
DIN 00567422
Director14 Feb 20197 yrs 9 moPanjon Limited
Athak Mahajan
DIN 10292097
Director31 Aug 20233 yrs 2 moPanjon Limited
Rajiv Kumar
DIN 10292119
Director31 Aug 20233 yrs 2 moPanjon Limited

People of Panjon

3 people are tracked at Panjon (3 in leadership); the tracked headcount is 6.

NameRoleGroup
FounderLeadership
Nagin Bhai Kothari
FounderLeadership
CEO & MDLeadership
Premium access

Complete people profiles for Panjon

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Panjon

Panjon is a publicly listed company on the BSE with ticker symbol PANJON in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date24 Feb 1994
  • Listed onBSE: 526345
  • Listed entityPanjon Ltd
  • Exchange sectorHealth technology
  • ISININE744D01019
  • Share price₹20.40 (+2.26% on the day) · 2026-10-14
  • Volume (last session)152

Financials of Panjon

Exchange-reported figures of Panjon Limited, the listed company behind Panjon (BSE: PANJON).

Financial Highlights

FY 2015-16 Β· Consolidated
Revenue
₹12.26 Cr
-37.1% YoY
EBITDA
−₹0.26 Cr
+94.4% YoY
Profit After Tax
₹0.37 Cr
+110.8% YoY
Net Worth
₹16.39 Cr
+2.3% YoY
Total Assets
₹17.80 Cr
+1.4% YoY
Total Debt
₹1.41 Cr
-7.2% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2015-16FY 2014-15
Income statement
Revenue12.2619.48
Revenue growth-37.1%-
EBITDA(0.26)(4.62)
EBITDA margin-2.1%-23.7%
Profit before tax0.03(4.71)
Net profit0.37(3.43)
Net profit margin+3.0%-17.6%
EPS (β‚Ή)0.230.00
Balance sheet
Total assets17.8017.55
Net worth16.3916.02
Total debt1.411.52
Cash & bank0.250.70
Net working capital14.8414.85
Cash flow
Cash from operations(0.20)0.89
Cash from investing(0.06)4.74
Cash from financing(0.19)(5.14)
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue47.6230.4612.556.098.4314.5426.43
Revenue growth+56.3%+142.7%+106.1%-27.8%-42.0%-45.0%-
EBITDA0.980.64(0.01)(0.01)(4.05)0.190.33
EBITDA margin+2.1%+2.1%-0.1%-0.2%-48.0%+1.3%+1.3%
Profit before tax0.710.540.160.11(4.02)0.190.20
Net profit0.600.410.160.80(4.16)0.10(0.02)
Net profit margin+1.3%+1.4%+1.3%+13.1%-49.4%+0.7%-0.1%
EPS (β‚Ή)0.040.230.090.52(2.68)0.06(0.02)
Balance sheet
Total assets-19.1916.2914.2613.4718.1418.28
Net worth-16.5514.8513.4812.6616.8116.73
Total debt-2.651.440.780.811.331.56
Cash & bank-0.442.721.471.440.310.28
Net working capital-11.8011.4510.018.3510.9310.56
Cash flow
Cash from operations-(4.34)(0.42)0.041.820.340.35
Cash from investing-(0.44)(0.21)(0.19)(0.19)(0.06)(0.51)
Cash from financing-2.501.880.18(0.51)(0.24)(0.07)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue11.028.0712.1214.1414.956.4213.8311.16
Revenue growth (YoY)-26.3%+25.7%-12.4%+26.7%+342.3%+207.2%--
Other income0.070.070.170.040.050.040.050.08
Total expenses10.767.8911.8713.8614.686.2213.5210.93
EBITDA0.260.180.250.280.270.200.310.23
EBITDA margin+2.4%+2.2%+2.1%+2.0%+1.8%+3.1%+2.2%+2.1%
Depreciation0.080.080.140.040.040.080.080.05
Interest0.090.080.100.070.040.060.060.06
Profit before tax0.160.090.180.210.240.100.220.20
Tax0.000.000.110.000.000.000.000.00

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 20 Nov 2026
ParticularsFY 2015-16FY 2014-15
Revenue12.2619.48
Revenue growth-37.1%-
Other income0.430.04
Total expenses12.5224.10
Employee cost0.370.24
EBITDA(0.26)(4.62)
EBITDA margin-2.1%-23.7%
Depreciation0.140.13
Interest0.000.00
Profit before tax0.03(4.71)
Tax(0.34)(1.28)
Net profit0.37(3.43)
Net profit margin+3.0%-17.6%
EPS (β‚Ή)0.230.00
ParticularsFY 2015-16FY 2014-15
Equity & liabilities
Share capital15.5015.50
Reserves & surplus0.890.52
Shareholders' funds (net worth)16.3916.02
Minority interest0.000.00
Secured loans1.231.42
Unsecured loans0.180.10
Total debt1.411.52
Total liabilities17.8017.55
Assets
Gross block6.646.59
Net block0.830.92
Capital work in progress0.000.00
Investments1.091.08
Inventories2.942.50
Sundry debtors8.789.83
Cash & bank balances0.250.70
Loans & advances3.122.33
Total current assets15.0915.36
Total current liabilities0.250.51
Net working capital14.8414.85
Total assets17.8017.55
ParticularsFY 2015-16FY 2014-15
Opening cash0.700.21
Net cash from operating activities(0.20)0.89
Net cash from investing activities(0.06)4.74
Net cash from financing activities(0.19)(5.14)
Net change in cash(0.44)0.49
Closing cash0.250.70
ParticularsFY 2015-16FY 2014-15
Growth
Sales growth-37.1%-
EBITDA growth+94.4%-
PBT growth+9998.0%+9997.0%
Net income growth+110.8%-
Profitability & leverage
Net income margin+3.0%-17.6%
Return on capital employed+0.1%0.0%
Return on net worth+1.8%0.0%
Debt / equity0.090.09
Long-term debt / equity0.080.09
Interest cover0.000.00
Efficiency & per share
Fixed asset turnover1.852.96
Inventory turnover4.517.79
Debtors turnover1.321.98
EPS (β‚Ή)0.230.00
Dividend per share (β‚Ή)0.000.00
Book value per share (β‚Ή)10.5710.34
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue11.028.0712.1214.1414.956.4213.8311.16
Revenue growth (YoY)-26.3%+25.7%-12.4%+26.7%+342.3%+207.2%--
Other income0.070.070.170.040.050.040.050.08
Total expenses10.767.8911.8713.8614.686.2213.5210.93
EBITDA0.260.180.250.280.270.200.310.23
EBITDA margin+2.4%+2.2%+2.1%+2.0%+1.8%+3.1%+2.2%+2.1%
Depreciation0.080.080.140.040.040.080.080.05
Interest0.090.080.100.070.040.060.060.06
Profit before tax0.160.090.180.210.240.100.220.20
Tax0.000.000.110.000.000.000.000.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue47.6230.4612.556.098.4314.5426.43
Revenue growth+56.3%+142.7%+106.1%-27.8%-42.0%-45.0%-
Other income0.300.310.450.380.300.330.29
Total expenses46.6429.8212.566.1012.4814.3526.10
Employee cost0.000.700.600.470.460.420.47
EBITDA0.980.64(0.01)(0.01)(4.05)0.190.33
EBITDA margin+2.1%+2.1%-0.1%-0.2%-48.0%+1.3%+1.3%
Depreciation0.300.230.220.210.200.230.27
Interest0.270.180.060.050.070.100.15
Profit before tax0.710.540.160.11(4.02)0.190.20
Tax0.110.130.00(0.69)0.140.090.22
Net profit0.600.410.160.80(4.16)0.10(0.02)
Net profit margin+1.3%+1.4%+1.3%+13.1%-49.4%+0.7%-0.1%
EPS (β‚Ή)0.040.230.090.52(2.68)0.06(0.02)
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-17.1716.3115.5015.5015.5015.50
Reserves & surplus-(0.62)(1.46)(2.02)(2.84)1.311.23
Shareholders' funds (net worth)-16.5514.8513.4812.6616.8116.73
Secured loans-2.561.310.280.810.860.89
Unsecured loans-0.090.130.500.000.470.67
Total debt-2.651.440.780.811.331.56
Total liabilities-19.1916.2914.2613.4718.1418.28
Assets
Gross block-8.468.047.837.847.667.59
Net block-1.090.900.910.940.971.12
Capital work in progress-0.000.000.000.000.000.00
Investments-1.101.081.081.071.071.08
Inventories-4.623.743.483.773.873.81
Sundry debtors-3.261.811.560.613.713.30
Cash & bank balances-0.442.721.471.440.310.28
Loans & advances-4.344.294.143.114.164.10
Total current assets-12.6612.5610.658.9312.0511.49
Total current liabilities-0.861.110.640.581.120.93
Net working capital-11.8011.4510.018.3510.9310.56
Total assets-19.1916.2914.2613.4718.1418.28
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-2.721.471.440.310.280.50
Net cash from operating activities-(4.34)(0.42)0.041.820.340.35
Net cash from investing activities-(0.44)(0.21)(0.19)(0.19)(0.06)(0.51)
Net cash from financing activities-2.501.880.18(0.51)(0.24)(0.07)
Net change in cash-(2.27)1.250.041.120.04(0.22)
Closing cash-0.442.721.471.440.310.28
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+56.3%+142.7%+106.1%-27.8%-42.0%-45.0%-
EBITDA growth+53.1%+6500.0%0.0%+99.8%-2231.6%-42.4%-
PBT growth+31.5%+237.5%+45.5%+9998.0%--5.0%-31.0%
Net income growth+46.3%+156.3%-80.0%+119.2%-4260.0%+600.0%-
Revenue CAGR (3Y)+98.5%+53.5%-4.8%-38.7%-31.3%-10.2%+23.7%
EBITDA CAGR (3Y)------23.2%-
Profitability & leverage
Net income margin+1.3%+1.4%+1.3%+13.1%-49.4%+0.7%-0.1%
Return on capital employed-+2.6%+0.9%+0.9%0.0%+1.4%0.0%
Return on net worth-+1.6%+0.6%+4.4%0.0%+0.5%0.0%
Debt / equity-0.130.080.060.070.090.10
Long-term debt / equity-0.010.01-1.900.050.070.08
Interest cover39.7143.90-26.09-22.73-1.65-250.00250.00
Efficiency & per share
Fixed asset turnover-3.691.580.781.091.913.61
Inventory turnover-7.293.481.682.213.797.11
Debtors turnover-12.027.455.613.904.1510.61
EPS (β‚Ή)0.040.230.090.52(2.68)0.06(0.02)
Dividend per share (β‚Ή)0.000.000.000.000.000.000.00
Book value per share (β‚Ή)0.009.649.118.708.1710.8510.79

Web traffic of Panjon

The website of Panjon (panjon.in) receives about 2K visits a month.

  • Monthly visits
    2K

    ▲ 37.6% vs previous month

Similar websites

Websites whose visitors overlap most with Panjon. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
static.icmwebserv.com
static.icmwebserv.com
100%
–
google.co.in
100%
77M#407View details
facebook.com
100%
12.1B#3View details

Top companies in Alternative Medicine Products

3 companies that operate in the same segment as Panjon (Alternative Medicine Products) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Homeopathic medicine manufacturing and online retail in India.
1898Noida, Uttar Pradesh, IndiaUSD 26.35 M1,192
Operates an online store specializing in ayurvedic and homeopathic medicines.
2016Delhi, Delhi, IndiaUSD 1.25 M16
Offers Ayurvedic treatments, consultations, and products for various diseases and wellness.
1992Faridabad, Haryana, IndiaUSD 10.08 M570
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Panjon

Premium access

Complete news archive for Panjon

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Panjon

Panjon was founded in 1964.

Panjon is headquartered in Indore, India. It is registered at Indore, Madhya Pradesh, India.

Jay Kothari is the CEO of Panjon, as recorded in our data.

Panjon has 6 employees.

The primary company behind Panjon, Panjon Limited, reported revenue of β‚Ή47.92 Cr for FY 2026, up 56% year on year.

Panjon was established in 1964 in Indore, India, as a manufacturer and supplier within the ayurvedic sector. Formulations based on traditional Indian medicine are produced and distributed from this location. Operations center on healthcare products, with oversight by CEO and MD Jay Kothari, alongside founders Nagin Kothari and Nagin Bhai Kothari. The domain panjon.in supports business activities.

Panjon offers PANJON Balm and Swad Digestive Drops.

Yes, Panjon is publicly traded on BSE under the ticker symbol PANJON.

Panjon operates through Panjon Limited.

The legal entities of Panjon currently have 7 directors, including Pooja Vishal Bhandari, Jay Kothari, Anju Kothari and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available